
IMATINIB MESYLATE
Human API designed for oncology therapeutic use. It is applicable in tablet dosage form.Benefits: Meets the requirements of USDMF, EDMF, KDMF and CEP
Reliable excipients and APIs meeting stringent pharmaceutical standards. Supporting safe, effective and compliant drug formulations.
Sort by




Let’s build your next solution together